Juniper Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Juniper Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 8% to $49,979,000. Profit margin reached -4%. Total operating expenses were $24,104,000.
Profit Margin
| 2013 | 29.22M | 6.70M | 22.94% |
|---|---|---|---|
| 2014 | 32.46M | 3.39M | 10.44% |
| 2015 | 37.55M | -2.13M | -5.68% |
| 2016 | 54.57M | 5.95M | 10.9% |
| 2017 | 49.97M | -2.06M | -4.12% |
JNP Income Statement (2013 – 2017)
| 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 49.97M | 54.57M | 37.55M | 32.46M | 29.22M |
Cost of revenue | 28.96M | 24.29M | 21.41M | 17.68M | 13.25M |
Gross profit | 21.01M | 30.28M | 16.14M | 14.77M | 15.97M |
Operating exp. | |||||
Research and development | 6.86M | 9.67M | 6.94M | 663K | 0 |
Selling and marketing | 1.85M | 1.25M | 1.24M | 1.70M | 438.95K |
Total operating expenses | 24.10M | 25.00M | 18.65M | 10.96M | 8.47M |
Operating income | -3.08M | 2.52M | -2.51M | 1.14M | 8.34M |
Other income (expenses), net | 840K | 3.52M | 382K | 3.23M | -1.61M |
Income before tax | -2.24M | 6.04M | -2.12M | 4.37M | 6.72M |
Income tax expense | -186K | 91K | 5K | 988K | 22.56K |
Net income | -2.06M | 5.95M | -2.13M | 3.39M | 6.70M |
Earnings per share | |||||
Basic EPS | -0.19 | 0.55 | -0.2 | 0.31 | 0.59 |
Diluted EPS | -0.19 | 0.55 | -0.2 | 0.27 | 0.52 |